Skip to main content Help with accessibility Skip to main navigation

EMPAGLIFLOZIN tablets (Jardiance®) for treating chronic heart failure with preserved or mildly reduced ejection fraction

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 26 - Sep - 2022
Body System:
Grey
EMPAGLIFLOZIN tablets (Jardiance®) for treating chronic heart failure with preserved or mildly reduced ejection fraction

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of EMPAGLIFLOZIN tablets (Jardiance®) for treating chronic heart failure with preserved or mildly reduced ejection fraction.